Celia Camacho-Toledano
YOU?
Author Swipe
View article: Vasculogenic potential of adipose tissue derived stem cells from patients with chronic spinal cord injury and pressure injuries
Vasculogenic potential of adipose tissue derived stem cells from patients with chronic spinal cord injury and pressure injuries Open
Limited vascularization and ischemia are major contributors to the chronicity of wounds, such as ulcers and traumatic injuries, which impose significant medical, social, and economic burdens. These challenges are particularly pronounced in…
View article: Circulating Myeloid-Derived Suppressor Cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis
Circulating Myeloid-Derived Suppressor Cell load and disease severity are associated to an enhanced oligodendroglial production in a murine model of multiple sclerosis Open
Background Multiple sclerosis (MS) is a chronic, inflammatory and demyelinating disease of the central nervous system (CNS) that is highly heterogeneous in terms of disease severity and tissue damage extent. Improving myelin restoration is…
View article: Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis
Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis Open
The biology of myeloid-derived suppressor cells (MDSCs) can be modified when grown on reduced graphene oxide (rGO) films. A higher oxidation state and roughness of rGO deplete MDSC activity by impacting on cell viability.
View article: Raw data for Camacho-Toledano et al._rGO_MDSCs_MS
Raw data for Camacho-Toledano et al._rGO_MDSCs_MS Open
Raw data from the study of the effect of rGO on MDSC biology in the context of multiple sclerosis
View article: Raw data for Camacho-Toledano et al._rGO_MDSCs_MS
Raw data for Camacho-Toledano et al._rGO_MDSCs_MS Open
Raw data from the study of the effect of rGO on MDSC biology in the context of multiple sclerosis
View article: GRAPHENE OXIDE AS A NOVEL IMMUNOTHERAPY TOOL FOR THE MODULATION OF MYELOID-DERIVED SUPPRESSOR CELL ACTIVITY IN THE CONTEXT OF MULTIPLE SCLEROSIS
GRAPHENE OXIDE AS A NOVEL IMMUNOTHERAPY TOOL FOR THE MODULATION OF MYELOID-DERIVED SUPPRESSOR CELL ACTIVITY IN THE CONTEXT OF MULTIPLE SCLEROSIS Open
Multiple Sclerosis (MS) is a chronic, inflammatory disease of the central nervous system. Despite the pharmacological arsenal approved for MS, there are treatment-reluctant patients for whom cell therapy appears as the only therapeutic alt…
View article: Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis
Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis Open
The increasing number of treatments that are now available to manage patients with multiple sclerosis (MS) highlights the need to develop biomarkers that can be used within the framework of individualized medicine. Fingolimod is a disease-…
View article: Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Regulatory Cells in Multiple Sclerosis: From Blood to Brain Open
Multiple sclerosis (MS) is a chronic, autoimmune, and neurodegenerative disease of the central nervous system (CNS) that affects myelin. The etiology of MS is unclear, although a variety of environmental and genetic factors are thought to …
View article: Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses Open
Background Tissue plasminogen activator (tPA) is a serine protease involved in fibrinolysis. It is released by endothelial cells, but also expressed by neurons and glial cells in the central nervous system (CNS). Interestingly, this enzyme…